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abstract
Keywords:

The “Collaborative work between the West and Asia” session was chaired by Dr Yih-Ing

Collaborative research

Hser and had three speakers. The speakers (and their topics) were: Dr Gavin Bart (Collab-

Implementing intervention research

orative addiction research in the United States and Asia), Dr Li Li (Implementing inter-

project
Research infrastructure

vention research projects in Asia), and Dr Le Minh Giang (Building research infrastructure
for international collaborative studies on substance use disorder and HIV: The case of
Hanoi Medical University/Vietnam).
Copyright ª 2013, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. All rights reserved.

1.

Introduction

This session covered topics ranging from the need for
collaborative research between the West and Asia, how to
develop and implement intervention research in Asian
countries, and ways to address challenges in developing a
research infrastructure in Asian countries.

2.

Presentations

Dr Gavin Bart, Director of the Hennepin County Medical
Center in Minnesota, USA, has been studying a sample of
opiate-dependent Hmong in Minnesota and has recently been
engaged in providing training for methadone clinicians in
Vietnam. He provided evidence that Hmong opiate addicts
demonstrate unique gene composition, high levels of psychiatric problems, and high retention in methadone maintenance treatment, even though they are on a low dosage of

methadone. He raised the question of whether standard
methadone dosing, which is mainly based on research among
Americans, is appropriate for non-Americans. His talk highlighted the need for collaborative research, because Asian
opioid addicts have unique cultural and genetic factors that
require tailored methadone treatment to optimize treatment
retention and outcomes. Details of this presentation can be
found in the article by Bart [1] included in this special issue.
Dr Li Li, Professor of the Department of Epidemiology at the
University of California, Los Angeles (UCLA) School of Public
Health, CA, USA, has led several research projects that involve
intervention development and testing in Asian countries. In
her talk, Dr Li described seven collaborative intervention projects conducted in China, Thailand, and Vietnam as examples
to illustrate different models of intervention development,
adaptation, and implementation. She identified and classified
three types of intervention development and implementation:
the adaptation of an existing model, the hybrid model, and the
locally developed model. Examples of each of these models
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were provided. The adaptation of an existing model has the
advantages of being theory- and evidence-based and having
available material, experience, and data, but it has the challenges of lacking local ownership, the models may not fit current targets, and there may be natural resistance from local
teams. Interventions that are developed using a hybrid model
have the advantages of being based on locally identified challenges, of incorporating effective elements, and of being locally
pilot-tested and supported, but they face the challenges of
lacking identity (due to deviations from the original intervention), difficulty in selection of effective elements, and a long
waiting period for evidence. Locally developed interventions
have the advantages of being locally owned, being culturally
appropriate, providing local capacity to develop and implement the intervention, and sustainability, but there are challenges because they are time consuming and of limited
generalizability. Therefore, a “one model fits all” approach will
not work, because different intervention development and
implementation processes pose specific challenges. It is
important to preserve core components of an effective intervention while incorporating local elements. Effective collaboration is the key, because involving local investigators and
experts in the design phase will enhance the acceptability and
sustainability of the intervention.
Dr. Le Minh Giang, who directs the VH-ATTC (Vietnam-HIV
Addiction Technology Transfer Center, Hanoi, Vietnam),
identified several key challenges in securing funding to
conduct research projects in Asia: limited research capacity,
lack of grant management experience and support, newly
developed institutional review board (IRB) capacity, and
reward structures that may not favor research. Using his own
experience as an example, Dr Le described efforts in Vietnam
to address these issues by establishing international collaborations to build research capacity, which may be critical to
achieving long-term outcomes for researchers and research
institutions in many parts of Asia.

3.

Discussion

Several concerns were raised during the discussion, including
the following.
(1) Regarding challenges in collaborative work in Asia, for
example, does the publication of scientific articles require

local governmental approval? The general experience, at
least in China, Vietnam, and Thailand, is that there is no
requirement for local government approval for scientific
publication. We were reminded that true collaboration
should be reflected in joint authorship (e.g., including local
collaborators as authors) as opposed to simply using the
local investigators to assist in data collection or project
implementation.
(2) Data security and confidentiality issues. Most investigators
are able to find ways to ensure data security and confidentiality. Genetic specimens are generally not allowed to
be taken out of China. Recent developments in mobile
health collection of ecologically momentary data via
smartphone may require additional procedures to overcome these challenges.
These presentations highlight the importance of establishing international collaborations that enhance long-term
research and outcomes beneficial to the West and Asia, and
eventually the promotion of global health. Further discussion
on potential collaborative research in the Asian region can be
found in the article by Hser et al [2] in this special issue.
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